Tumor markers were also elevated, including AFP (median [IQR], 42.1 [9.0-247.7] vs 11.3 [3.9-190.1] ng/mL) and PIVKA-II (median [IQR], 174.0 [45.7-942.7] vs 54.0 [25.0-329.0] mAU/mL) levels (both P < .001). Here, AFP is linked to neoplasm.